Zevra Therapeutics, Inc. ZVRA Operating margin

Operating margin at other companies

BioMarin PharmaceuticalsBMRN

19.9%+7.2pp

Ultragenyx PharmaceuticalRARE

-73.6%-7.3pp

RFL

Rafael Holdings, Inc.RFL

-3,717.2%+1,952pp

Rigel PharmaceuticalsRIGL

41.6%+19.9pp

XER

Xeris Biopharma Holdings, Inc.XERS

10.9%+8.4pp

Theravance BiopharmaTBPH

1.2%+0.6pp

FAQ

What is Zevra Therapeutics, Inc.'s operating margin?

Zevra Therapeutics, Inc. (ZVRA) reported operating margin of -103.9% in Q3 2025.

How has Zevra Therapeutics, Inc.'s operating margin changed year-over-year?

Zevra Therapeutics, Inc.'s operating margin increased by 70.7% year-over-year, from -354.2% to -103.9%.

What is the long-term trend for Zevra Therapeutics, Inc.'s operating margin?

Over 3 years (2020 to 2024), Zevra Therapeutics, Inc.'s operating margin has grown at a 105.9% compound annual growth rate (CAGR), from -42.2% to -368.5%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.